Advertisement
Nanotechnology and Nanobiology Against Multi-drug Resistant Bacteria
Scope
The emergence of multidrug-resistant bacteria is a global threat. In the absence of available treatments, alternative therapies are needed. Nanotechnology and nanobiology, from nanoparticles to bacteriophages, are promising tools to combat superbugs. In this special issue, the aim is to provide an overview of new technologies and approaches that will contribute to design novel antimicrobials.
Topics of particular interest include, but are not limited to:
- Nanotechnology and nanobiology to combat antimicrobial resistance
- Phage and phage-derived therapies
- Nanoparticles
- New challenges against multi-drug resistant bacteria
Special Issue Editor
Pilar Domingo-Calap, PhD
BioDesign Research Associate Editor
Institute for Integrative Systems Biology
University of Valencia, Spain
www.uv.es/docapi
Submission Instructions
Please select "Special Issue: Nanotechnology and Nanobiology Against Multi-drug Resistant Bacteria" as the section/category during the submission process. Please also indicate in your cover letter that your submission is intended for inclusion in the special issue.
Submission Deadline: May 31, 2023
Table of Contents
- Bacterial infections are a major threat to the human healthcare system worldwide, as antibiotics are becoming less effective due to the emergence of multidrug-resistant strains. Therefore, there is a need to explore nontraditional antimicrobial ...
